0.9865
price up icon8.89%   0.0805
after-market 시간 외 거래: .94 -0.0465 -4.71%
loading
전일 마감가:
$0.906
열려 있는:
$0.9
하루 거래량:
4.92M
Relative Volume:
0.78
시가총액:
$32.25M
수익:
-
순이익/손실:
$-563.30K
주가수익비율:
-4.9424
EPS:
-0.1996
순현금흐름:
$-22.23M
1주 성능:
+124.15%
1개월 성능:
+103.40%
6개월 성능:
+10.37%
1년 성능:
-51.11%
1일 변동 폭
Value
$0.8746
$1.06
1주일 범위
Value
$0.77
$1.59
52주 변동 폭
Value
$0.38
$2.05

Promis Neurosciences Inc Stock (PMN) Company Profile

Name
명칭
Promis Neurosciences Inc
Name
전화
416-847-6898
Name
주소
SUITE 200, 1920 YONGE STREET, TORONTO
Name
직원
8
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
PMN's Discussions on Twitter

PMN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PMN
Promis Neurosciences Inc
0.9865 29.62M 0 -563.30K -22.23M -0.1996
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Promis Neurosciences Inc 주식(PMN)의 최신 뉴스

pulisher
Jul 25, 2025

What drives ProMIS Neurosciences Inc. stock priceMassive portfolio appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Analysts Are Bullish on Top Healthcare Stocks: ProMIS Neurosciences (PMN), Bruker (BRKR) - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

ProMIS Neurosciences Alights on Path to Novel Alzheimer’s Treatment - StocksToTrade

Jul 25, 2025
pulisher
Jul 25, 2025

ProMIS Neurosciences Inc. Stock Analysis and ForecastExplosive earnings growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about ProMIS Neurosciences Inc. stockAccelerated earnings growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

When is the best time to buy ProMIS Neurosciences Inc. stockHigh-impact stock picks - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is ProMIS Neurosciences Inc. stock a growth or value playFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will ProMIS Neurosciences Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

ProMIS Neurosciences Gains FDA Fast Track for PMN310 - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Is ProMIS Neurosciences Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Earnings Misses And Clinical Hurdles Rattle Major Stocks - Finimize

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $3.2M Fundraising Initiatives - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Still undervalued? ProMIS Neurosciences keeps $9.50 target price at Leede - Cantech Letter

Jul 22, 2025
pulisher
Jul 22, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 24.56% Intraday—Is the FDA Fast Track Outpacing Investor Sentiment? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 28% Intraday—Is This the Catalyst No One Saw Coming? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What makes ProMIS Neurosciences Inc. stock price move sharplyBreakout Level Watch - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Buy Rating for ProMIS Neurosciences Driven by Fast Track Designation and Promising Alzheimer’s Treatment Potential - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces $0.8M registered direct offering - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces private placement financing - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences stock gets FDA Fast Track designation for PMN310 - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences (PMN) Secures Funding to Enhance Therapeuti - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing | PMN Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $2.4 Million PIPE Financing for Clinical Development of PMN310 - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Drops 9.82% Amid ICICI Bank's Strong Earnings - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Secures $9.2M Funding Boost: Accelerates Novel Alzheimer's Treatment Development - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences ends at-the-market agreement and receives FDA fast track for PMN310 - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

3 Penny Stocks to Watch Now, 7/22/25 - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Inc Inc. (PMN) Price Performance: The Role of Supply and Demand - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 149.77% intraday after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Shares Of Micro Cap Biotech Surge After Breakthrough FDA Designation - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation | 2025-07-21 | Investing News - Stockhouse

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 134%—What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences (PMN) up more than 300% since Jul 8 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Promis Neurosciences shares surge 250% intraday after FDA grants Fast Track designation for PMN310 Alzheimer's treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences: Stock Surge Insight - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 157% on FDA Fast Track Designation – What’s Fueling This Volatile Rally? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock soars after FDA grants Fast Track for Alzheimer’s drug - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Surges: Analyzing Recent Moves - timothysykes.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 21.37% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310 - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today? - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 17.50% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025

Promis Neurosciences Inc (PMN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):